Endonovo Therapeutics Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.02 |
Market Cap |
$9.77 M |
Shares Outstanding |
558.16 M |
Public Float |
385.89 M |
Address |
6320 Canoga Avenue Woodland Hills California 91367 United States |
Employees | - |
Website | http://www.endonovo.com |
Updated | 07/08/2019 |
Endonovo Therapeutics, Inc. is a biotechnology company, which engages in developing off bioelectronic approach to regenerative medicine. It operates through the Intellectual Property Management and Commercialization segment. The company was founded on May 26, 2011 and is headquartered in Woodland Hills, CA. |